Chickpeas vs Fava Beans – Which is Healthier?

10almonds is reader-supported. We may, at no cost to you, receive a portion of sales if you purchase a product through a link in this article.

Our Verdict

When comparing chickpeas to fava beans, we picked the chickpeas.

Why?

Although both are great, it still wasn’t even close. It’s one of those instances of “a very nutritious food looks bad standing next to a truly top-tier superfood”:

In terms of macros, chickpeas have more fiber, carbs, and protein, thus winning in this category.

In the category of vitamins, chickpeas have more of vitamins A, B1, B5, B6, B7, B9, C, E, and K, while fava beans have more of vitamins B2 and B3, giving chickpeas a 9:2 victory in this round.

Looking at minerals, chickpeas have more calcium, copper, iron, magnesium, manganese, phosphorus, potassium, selenium, and zinc, while fava beans are not higher in any minerals, giving chickpeas a total win here.

To spare fava beans’ blushes at this point, we should mention that fava beans were hot on chickpeas’ heels for all of those minerals, except perhaps manganese, so really: fava beans do have plenty to offer, just, chickpeas have even more.

Adding up the sections makes for a very clear overall win for chickpeas, but do enjoy either or both, since as we say, they’re both great, and diversity is good!

Want to learn more?

You might like:

The High-Protein, High-Fiber Superfood Salad You’ll Want To Enjoy Daily

Enjoy!

Don’t Forget…

Did you arrive here from our newsletter? Don’t forget to return to the email to continue learning!

Learn to Age Gracefully

Join the 98k+ American women taking control of their health & aging with our 100% free (and fun!) daily emails:

  • In Crisis, She Went to an Illinois Facility. Two Years Later, She Still Isn’t Able to Leave.

    10almonds is reader-supported. We may, at no cost to you, receive a portion of sales if you purchase a product through a link in this article.

    Series: Culture of Cruelty:Inside Illinois’ Mental Health System

    State-run facilities in Illinois are supposed to care for people with mental and developmental disabilities. But patients have been subjected to abuse, neglect and staff misconduct for decades, despite calls for change.

    Kaleigh Rogers was in crisis when she checked into a state-run institution on Illinois’ northern border two years ago. Rogers, who has cerebral palsy, had a mental health breakdown during the pandemic and was acting aggressively toward herself and others.

    Before COVID-19, she had been living in a small group home; she had been taking college classes online and enjoyed going out with friends, volunteering and going to church. But when her aggression escalated, she needed more medical help than her community setting could provide.

    With few viable options for intervention, she moved into Kiley Developmental Center in Waukegan, a much larger facility. There, she says she has fewer freedoms and almost nothing to do, and was placed in a unit with six other residents, all of whom are unable to speak. Although the stay was meant to be short term, she’s been there for two years.

    The predicament facing Rogers and others like her is proof, advocates say, that the state is failing to live up to the promise it made in a 13-year-old federal consent decree to serve people in the community.

    Rogers, 26, said she has lost so much at Kiley: her privacy, her autonomy and her purpose. During dark times, she cries on the phone to her mom, who has reduced the frequency of her visits because it is so upsetting for Rogers when her mom has to leave.

    The 220-bed developmental center about an hour north of Chicago is one of seven in the state that have been plagued by allegations of abuse and other staff misconduct. The facilities have been the subject of a monthslong investigation by Capitol News Illinois and ProPublica about the state’s failures to correct poor conditions for people with intellectual and developmental disabilities. The news organizations uncovered instances of staff who had beaten, choked, thrown, dragged and humiliated residents inside the state-run facilities.

    Advocates hoped the state would become less reliant on large institutions like these when they filed a lawsuit in 2005, alleging that Illinois’ failure to adequately fund community living options ended up segregating people with intellectual and developmental disabilities from society by forcing them to live in institutions. The suit claimed Illinois was in direct violation of a 1999 U.S. Supreme Court decision in another case, which found that states had to serve people in the most integrated setting of their choosing.

    Negotiations resulted in a consent decree, a court-supervised improvement plan. The state agreed to find and fund community placements and services for individuals covered by the consent decree, thousands of adults with intellectual and developmental disabilities across Illinois who have put their names on waiting lists to receive them.

    Now, the state has asked a judge to consider ending the consent decree, citing significant increases in the number of people receiving community-based services. In a court filing in December, Illinois argued that while its system is “not and never will be perfect,” it is “much more than legally adequate.”

    But advocates say the consent decree should not be considered fulfilled as long as people with disabilities continue to live without the services and choices that the state promised.

    Across the country, states have significantly downsized or closed their large-scale institutions for people with developmental and intellectual disabilities in favor of smaller, more integrated and more homelike settings.

    But in Illinois, a national outlier, such efforts have foundered. Efforts to close state-operated developmental centers have been met with strong opposition from labor unions, the communities where the centers are located, local politicians and some parents.

    U.S. District Judge Sharon Johnson Coleman in Chicago is scheduled in late summer to decide whether the state has made enough progress in building up community supports to end the court’s oversight.

    For some individuals like Rogers, who are in crisis or have higher medical or behavioral challenges, the state itself acknowledges that it has struggled to serve them in community settings. Rogers said she’d like to send this message on behalf of those in state-operated developmental centers: “Please, please get us out once and for all.”

    “Living Inside a Box”

    Without a robust system of community-based resources and living arrangements to intervene during a crisis, state-operated developmental centers become a last resort for people with disabilities. But under the consent decree agreement, the state, Equip for Equality argues, is expected to offer sufficient alternative crisis supports to keep people who want them out of these institutions.

    In a written response to questions, Rachel Otwell, a spokesperson for the Illinois Department of Human Services, said the state has sought to expand the menu of services it offers people experiencing a crisis, in an effort to keep them from going into institutions. But Andrea Rizor, a lawyer with Equip for Equality, said, “They just don’t have enough to meet the demand.”

    For example, the state offers stabilization homes where people can live for 90 days while they receive more intensive support from staff serving the homes, including medication reviews and behavioral interventions. But there are only 32 placements available — only four of them for women — and the beds are always full, Rizor said.

    Too many people, she said, enter a state-run institution for short-term treatment and end up stuck there for years for various reasons, including shortcomings with the state’s discharge planning and concerns from providers who may assume those residents to be disruptive or difficult to serve without adequate resources.

    That’s what happened to Rogers. Interruptions to her routine and isolation during the pandemic sent her anxiety and aggressive behaviors into overdrive. The staff at her community group home in Machesney Park, unsure of what to do when she acted out, had called the police on several occasions.

    Doctors also tried to intervene, but the cocktail of medications she was prescribed turned her into a “zombie,” Rogers said. Stacey Rogers, her mom and legal guardian, said she didn’t know where else to turn for help. Kiley, she said, “was pretty much the last resort for us,” but she never intended for her daughter to be there for this long. She’s helped her daughter apply to dozens of group homes over the past year. A few put her on waitlists; most have turned her down.

    “Right now, all she’s doing is living inside a box,” Stacey Rogers said.

    Although Rogers gave the news organizations permission to ask about her situation, IDHS declined to comment, citing privacy restrictions. In general, the IDHS spokesperson said that timelines for leaving institutions are “specific to each individual” and their unique preferences, such as where they want to live and speciality services they may require in a group home.

    Equip for Equality points to people like Rogers to argue that the consent decree has not been sufficiently fulfilled. She’s one of several hundred in that predicament, the organization said.

    “If the state doesn’t have capacity to serve folks in the community, then the time is not right to terminate this consent decree, which requires community capacity,” Rizor said.

    Equip for Equality has said that ongoing safety issues in these facilities make it even more important that people covered by the consent decree not be placed in state-run institutions. In an October court brief, citing the news organizations’ reporting, Equip for Equality said that individuals with disabilities who were transferred from community to institutional care in crisis have “died, been raped, and been physically and mentally abused.”

    Over the summer, an independent court monitor assigned to provide expert opinions in the consent decree, in a memo to the court, asked a judge to bar the state from admitting those individuals into its institutions.

    In its December court filing, the state acknowledged that there are some safety concerns inside its state-run centers, “which the state is diligently working on,” as well as conditions inside privately operated facilities and group homes “that need to be addressed.” But it also argued that conditions inside its facilities are outside the scope of the consent decree. The lawsuit and consent decree specifically aimed to help people who wanted to move out of large private institutions, but plaintiffs’ attorneys argue that the consent decree prohibits the state from using state-run institutions as backup crisis centers.

    In arguing to end the consent decree, the state pointed to significant increases in the number of people served since it went into effect. There were about 13,500 people receiving home- and community-based services in 2011 compared with more than 23,000 in 2023, it told the court.

    The state also said it has significantly increased funding that is earmarked to pay front-line direct support professionals who assist individuals with daily living needs in the community, such as eating and grooming.

    In a statement to reporters, the human services department called these and other improvements to the system “extraordinary.”

    Lawyers for the state argued that those improvements are enough to end court oversight.

    “The systemic barriers that were in place in 2011 no longer exist,” the state’s court filing said.

    Among those who were able to find homes in the community is Stanley Ligas, the lead plaintiff in the lawsuit that led to the consent decree. When it was filed in 2005, he was living in a roughly 100-bed private facility but wanted to move into a community home closer to his sister. The state refused to fund his move.

    Today, the 56-year-old lives in Oswego with three roommates in a house they rent. All of them receive services to help their daily living needs through a nonprofit, and Ligas has held jobs in the community: He previously worked in a bowling alley and is now paid to make public appearances to advocate for others with disabilities. He lives near his sister, says he goes on family beach vacations and enjoys watching professional wrestling with friends. During an interview with reporters, Ligas hugged his caregiver and said he’s “very happy” and hopes others can receive the same opportunities he’s been given.

    While much of that progress has come only in recent years, under Gov. JB Pritzker’s administration, it has proven to be vulnerable to political and economic changes. After a prolonged budget stalemate, the court in 2017 found Illinois out of compliance with the Ligas consent decree.

    At the time, late and insufficient payments from the state had resulted in a staffing crisis inside community group homes, leading to escalating claims of abuse and neglect and failures to provide routine services that residents relied on, such as help getting to work, social engagements and medical appointments in the community. Advocates worry about what could happen under a different administration, or this one, if Illinois’ finances continue to decline as projected.

    “I acknowledge the commitments that this administration has made. However, because we had so far to come, we still have far to go,” said Kathy Carmody, chief executive of The Institute on Public Policy for People with Disabilities, which represents providers.

    While the wait for services is significantly shorter than it was when the consent decree went into effect in 2011, there are still more than 5,000 adults who have told the state they want community services but have yet to receive them, most of them in a family home. Most people spend about five years waiting to get the services they request. And Illinois continues to rank near the bottom in terms of the investment it makes in community-based services, according to a University of Kansas analysis of states’ spending on services for people with intellectual and developmental disabilities.

    Advocates who believe the consent decree has not been fulfilled contend that Illinois’ continued reliance on congregate settings has tied up funds that could go into building up more community living options. Each year, Illinois spends about $347,000 per person to care for those in state-run institutions compared with roughly $91,000 per person spent to support those living in the community.

    For Rogers, the days inside Kiley are long, tedious and sometimes chaotic. It can be stressful, but Rogers told reporters that she uses soothing self-talk to calm herself when she feels sad or anxious.

    “I tell myself: ‘You are doing good. You are doing great. You have people outside of here that care about you and cherish you.’”

    This article is republished from ProPublica under a Creative Commons license. Read the original article.

    Share This Post

  • How To Make Disease Disappear – by Dr. Rangan Chatterjee

    10almonds is reader-supported. We may, at no cost to you, receive a portion of sales if you purchase a product through a link in this article.

    We’ve previously reviewed a number of other books by Dr. Chatterjee, all of them good. This one’s perhaps his most generalized book that we’ve read, though it has a lot of overlap with his “Four Pillar Plan”, and indeed, each of those four pillars (relax, eat, move, sleep) gets a section in this book, each section getting 5 chapters on how to optimize the thing in question.

    You may be wondering why “relax” and “sleep” don’t get one section between them; the idea of “relax” is about stress management, mindfulness (especially mindful eating), and so forth. Thus, it does connect to the other sections, but is very much its own topic also.

    The premise is, as per the title, to “make disease disappear”. The way to do that, he argues, is through engaging in progressively healthy habits to accumulate chronic good health. With the 20 things you will be doing from the first four sections of 5 chapters each, you will be soon be well on your way, and he finishes up with “finding your balance”—because the trick, he says, is not to focus unduly on one, two, or even three of the pillar(s) as the expense of the other(s), but to ensure a good balance between them.

    The style is light pop-science with a focus on readability; there are many personal accounts and examples, but nothing brash or self-serving, simply, illustrative. Indeed, he shows his mistakes as much as his successes, that we may learn from them.

    Bottom line: this is, in essence, a rehash of his Four Pillar Plan, but tailored for an American audience. As such, American readers may find it more easily applicable than the previous book. Either way, the quality is just as good, so by all means take your pick between them.

    Click here to check out How To Make Disease Disappear, and make disease disappear!

    Share This Post

  • Arthritis-Proof Your Life – by Dr. Michelle Cook

    10almonds is reader-supported. We may, at no cost to you, receive a portion of sales if you purchase a product through a link in this article.

    First, a note about that title of doctor. Sometimes we will mention “you may be wondering, is that an MD or a PhD? It’s both!” because there is some physician-scientist with an MD plus a PhD in, say, neurology or biochemistry of some kind or be it what it may. In this case, the author has two claims to doctorship: a PhD in traditional natural medicine, and a “DNP”, the “doctor of naturopathic medicine” qualification which is usually a four-year degree, and/but is not generally considered a medical degree, or equivalent, or similar.

    This may explain some medical errors in the book, such as the claims that “Fibromyalgia is a type of arthritis” (it isn’t, and in fact by definition will only be diagnosed as such if other disorders such as arthritis have been ruled out as the cause of the symptoms) and “Tylenol is a non-steroidal anti-inflammatory drug” (it isn’t, it’s an antipyretic analgesic, which despite the similar uses and shared reference to the imagery of fire, is a completely different class of drugs and works differently to NSAIDs).

    However, it’s not all bad. One thing this book has as a strength is that it offers a lot of things to try, if you’ve already tried everything else, ranging from dietary tweaks to try outside of the usual anti-inflammatory recommendations (but yes, those too), complementary medicine methods such as acupressure and aromatherapy, and the two-way relationship between arthritis and mental health.

    The style is bold and lively, and proceeds without citations to interrupt one’s flow, though there is a bibliography at the back, mostly for references to herbalism.

    Bottom line: if you have arthritis, have tried many things, and are looking for more things to try, this book may have options you wouldn’t have thought of!

    Click here to check out Arthritis-Proof Your Life, and get creative with your problem-solving!

    Share This Post

  • Exercise… In A Pill?

    10almonds is reader-supported. We may, at no cost to you, receive a portion of sales if you purchase a product through a link in this article.

    Exercise is, of course, vitally important for many aspects of health. So, can it be replaced by a pill?

    And the answer is: in part, at least!

    Here’s how…

    Trick the muscles; trick the brain

    First, what this won’t do:

    • Give all the cardiovascular benefits of exercise
    • Give all the strength (muscular or skeletal) benefits of exercise

    You may be thinking: isn’t that everything then?

    And no it isn’t, because the word “all” was doing a fair bit of heavy-lifting (so to speak) in those bullet points.

    For example, there are a lot of physiological benefits, such as to muscle metabolism and knock-on effects in brain health (not just due to improved circulation, but also due to assorted chemicals being released too).

    Researchers (Dr. Bernard Jasmin et al.) noted that in cases of depression, exercise can be similarly effective to first-line treatments such as medication and psychotherapy, but adherence is often lower and drop-out rates are higher than with antidepressants despite their side effects.

    It’s not laziness, either; symptoms such as low energy, lack of motivation, and anhedonia—along with socio-economic pressures, co-morbidities, inexperience, time constraints, older age, stroke history, and functional limitations—can prevent people from starting or maintaining exercise.

    You can learn more about this here, by the way: Laziness Is A Scooby-Doo Villain ← which means: to tackle it requires doing a Scooby-Doo unmasking. You know, when the mystery-solving gang has the “ghost” or “monster” tied to a chair, and they pull the mask off, to reveal that there was no ghost etc, and in fact it was a real estate scammer or somesuch. So it is with “laziness” too; there’s always something else underneath (e.g. the debilitating factors we mentioned in the previous paragraph)

    Social psychologist Dr. Devon Price wrote about this (not with that metaphor though) in his book: Laziness Does Not Exist – by Dr. Devon Price

    So the trick that Dr. Jasmin et al. went for is making use of muscle as a signalling organ that communicates with the brain.

    This is because of the muscle–brain axis: skeletal muscle makes up approximately 40–50% of adult body mass and releases cehmicals collectively known as a myosecretome during contraction, which can reduce inflammation and increase neurotrophic factors that support brain health.

    Sounds like a job for exercise mimetics!

    What exercise mimetics are: exercise mimetics—which can be called “exercise pills”—are natural or synthetic compounds that activate key endurance-related signalling pathways in skeletal muscle, shifting fibres towards slower, more oxidative properties without physical training.

    For example, compounds such as AICAR, GW501516, metformin, resveratrol, NAD+ boosters, and urolithin A, all of which may alter muscle metabolism and the composition of molecules released into the bloodstream. We wrote about several of these, by the way, in: Dr. Greger’s Anti-Aging Eight

    Which can help a lot in this case too, as you can see in the paper itself: Exercise mimetics as unexplored therapeutics for treating depression

    Want to learn more?

    If you like this, then you’ll love the already-available…

    Mediterranean Diet… In A Pill?

    Take care!

    Don’t Forget…

    Did you arrive here from our newsletter? Don’t forget to return to the email to continue learning!

    Learn to Age Gracefully

    Join the 98k+ American women taking control of their health & aging with our 100% free (and fun!) daily emails:

  • 10 Mistakes To Sabotage Your Ozempic Progress

    10almonds is reader-supported. We may, at no cost to you, receive a portion of sales if you purchase a product through a link in this article.

    Ozempic has a good reputation for getting reliable results, but there are ways to mess it up:

    It’s not just inject-and-go

    We’ll not keep the 10 ways a secret; they are:

    1. Increasing the dose too quickly: avoid cranking doses up too high too quickly, to prevent severe nausea, appetite suppression, and muscle loss. It’s worth being aware that high doses without proper management can lead to metabolic health disasters.
    2. Pushing through side effects: severe nausea or vomiting means you probably have an unhelpfully high dose; consult your prescribing doctor—it’s easy to feel “more is better; I don’t want to have less!”, but there really is a sweet spot, and if you’re not in it, then adjustments are needed in order to find it.
    3. Eating nutritionally scant food: reducing the quantity of unhealthy food isn’t enough—please prioritize nutrient-rich foods instead. Remember, “it’s not the calories in your food; it’s the food in your calories”.
    4. Consuming fried food and refined carbs: their general metabolic woes aside, fried foods and ultra-refined carbs can exacerbate nausea and other side effects, so it really is best to skip them. The good news is that Ozempic will help overcome those cravings more easily.
    5. Neglecting muscle protection: especially women, especially middle-aged or older, are at higher risk of osteoporosis and should maintain muscle mass (strong muscles and strong bones go together, by necessity). So, eat protein and do resistance training!
    6. Assuming it’s a monotherapy: GLP-1 drugs work best as part of a holistic protocol, including proper nutrition, strength training, and hormone therapy if appropriate.
    7. Not addressing metabolic health first: GLP-1 drugs are less effective in people with poor baseline metabolic health, so there’s a bit of a catch-22 here, but it’s important to be aware of. Fortunately, Ozempic and adopting a healthy lifestyle will each make the other work better.
    8. Neglecting comprehensive treatment plans: in other words, going through the motions of a holistic protocol and then expecting Ozempic to do all the work.
    9. Upping doses to overcome plateaus: plateaus often signal other issues (e.g. lack of protein, no strength training), so do address these before increasing dosage.
    10. Lack of collaboration with doctors: the human body is complex, and what’s going on metabolically is complex too, so there’s a lot a layperson can easily miss. For that matter, there’s a lot that doctors can easily miss too, but more heads are better than one.

    For more on all of these, enjoy:

    Click Here If The Embedded Video Doesn’t Load Automatically!

    Want to learn more?

    You might also like:

    5 Ways To Naturally Boost The Ozempic Effect

    Take care!

    Don’t Forget…

    Did you arrive here from our newsletter? Don’t forget to return to the email to continue learning!

    Learn to Age Gracefully

    Join the 98k+ American women taking control of their health & aging with our 100% free (and fun!) daily emails:

  • Which gut drugs might end up in a lawsuit? Are there really links with cancer and kidney disease? Should I stop taking them?

    10almonds is reader-supported. We may, at no cost to you, receive a portion of sales if you purchase a product through a link in this article.

    Common medicines used to treat conditions including heartburn, reflux, indigestion and stomach ulcers may be the subject of a class action lawsuit in Australia.

    Lawyers are exploring whether long-term use of these over-the-counter and prescription drugs are linked to stomach cancer or kidney disease.

    The potential class action follows the settlement of a related multi-million dollar lawsuit in the United States. Last year, international pharmaceutical company AstraZeneca settled for US$425 million (A$637 million) after patients made the case that two of its drugs caused significant and potentially life-threatening side effects.

    Specifically, patients claimed the company’s drugs Nexium (esomeprazole) and Prilosec (omeprazole) increased the risk of kidney damage.

    Doucefleur/Shutterstock

    Which drugs are involved in Australia?

    The class of drugs we’re talking about are “proton pump inhibitors” (sometimes called PPIs). In the case of the Australian potential class action, lawyers are investigating:

    • Nexium (esomeprazole)
    • Losec, Asimax (omeprazole)
    • Somac (pantoprazole)
    • Pariet (rabeprazole)
    • Zoton (lansoprazole).

    Depending on their strength and quantity, these medicines are available over-the-counter in pharmacies or by prescription.

    They have been available in Australia for more than 20 years and are in the top ten medicines dispensed through the Pharmaceutical Benefits Scheme.

    They are used to treat conditions exacerbated by stomach acid. These include heartburn, gastric reflux and indigestion. They work by blocking the protein responsible for pumping acid into the stomach.

    These drugs are also prescribed with antibiotics to treat the bacterium Helicobacter pylori, which causes stomach ulcers and stomach cancer.

    Helicobacter pylori in the gut
    This class of drugs is also used with antibiotics to treat Helicobacter pylori infections. nobeastsofierce/Shutterstock

    What do we know about the risks?

    Appropriate use of proton pump inhibitors plays an important role in treating several serious digestive problems. Like all medicines, there are risks associated with their use depending on how much and how long they are used.

    When proton pump inhibitors are used appropriately for the short-term treatment of stomach problems, they are generally well tolerated, safe and effective.

    Their risks are mostly associated with long-term use (using them for more than a year) due to the negative effects from having reduced levels of stomach acid. In elderly people, these include an increased risk of gut and respiratory tract infections, nutrient deficiencies and fractures. Long-term use of these drugs in elderly people has also been associated with an increased risk of dementia.

    In children, there is an increased risk of serious infection associated with using these drugs, regardless of how long they are used.

    How about the cancer and kidney risk?

    Currently, the Australian consumer medicine information sheets that come with the medicines, like this one for esomeprazole, do not list stomach cancer or kidney injury as a risk associated with using proton pump inhibitors.

    So what does the evidence say about the risk?

    Over the past few years, there have been large studies based on observing people in the general population who have used proton pump inhibitors. These studies have found people who take them are almost two times more likely to develop stomach cancer and 1.7 times more likely to develop chronic kidney disease when compared with people who are not taking them.

    In particular, these studies report that users of the drugs lansoprazole and pantoprazole have about a three to four times higher risk than non-users of developing chronic kidney disease.

    While these observational studies show a link between using the drugs and these outcomes, we cannot say from this evidence that one causes the other.

    Human kidney illustration with blood vessels
    Researchers have not yet shown these drugs cause kidney disease. crystal light/Shutterstock

    What can I do if I’m worried?

    Several digestive conditions, especially reflux and heartburn, may benefit from simple dietary and lifestyle changes. But the overall evidence for these is not strong and how well they work varies between individuals.

    But it may help to avoid large meals within two to three hours before bed, and reduce your intake of fatty food, alcohol and coffee. Eating slowly and getting your weight down if you are overweight may also help your symptoms.

    There are also medications other than proton pump inhibitors that can be used for heartburn, reflux and stomach ulcers.

    These include over-the-counter antacids (such as Gaviscon and Mylanta), which work by neutralising the acidic environment of the stomach.

    Alternatives for prescription drugs include nizatidine and famotidine. These work by blocking histamine receptors in the stomach, which decreases stomach acid production.

    If you are concerned about your use of proton pump inhibitors it is important to speak with your doctor or pharmacist before you stop using them. That’s because when you have been using them for a while, stopping them may result in increased or “rebound” acid production.

    Nial Wheate, Professor and Director – Academic Excellence, Macquarie University; Joanna Harnett, Senior Lecturer – Sydney Pharmacy School, Faculty of Medicine and Health, University of Sydney, and Wai-Jo Jocelin Chan, Pharmacist and Associate Lecturer, University of Sydney

    This article is republished from The Conversation under a Creative Commons license. Read the original article.

    Don’t Forget…

    Did you arrive here from our newsletter? Don’t forget to return to the email to continue learning!

    Learn to Age Gracefully

    Join the 98k+ American women taking control of their health & aging with our 100% free (and fun!) daily emails: